[1]
|
Zhu, C.Y., Sturgeon, C. and Yeh, M.W. (2020) Diagnosis and Management of Primary Hyperparathyroidism. JAMA, 323, 1186-1187. https://doi.org/10.1001/jama.2020.0538
|
[2]
|
Nilsson, I.L. (2019) Primary Hyperparathyroidism: Should Surgery Be Performed on All Patients? Current Evidence and Residual Uncertainties. Journal of Internal Medicine, 285, 149-164. https://doi.org/10.1111/joim.12840
|
[3]
|
Hagström, E., Hellman, P., Larsson, T.E., et al. (2009) Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community. Circulation, 119, 2765-2771. https://doi.org/10.1161/CIRCULATIONAHA.108.808733
|
[4]
|
Pepe, J., Cipriani, C., Sonato, C., et al. (2017) Cardiovascular Manifestations of Primary Hyperparathyroidism: A Narrative Review. European Journal of Endocrinology, 177, R297-R308. https://doi.org/10.1530/EJE-17-0485
|
[5]
|
Fujii, H. (2018) Association between Parathyroid Hormone and Cardiovascular Disease. Therapeutic Apheresis and Dialysis, 22, 236-241. https://doi.org/10.1111/1744-9987.12679
|
[6]
|
何春华, 王金芳, 王清国. 原发性甲状旁腺功能亢进症患者的心血管风险研究进展[J]. 中国全科医学, 2021, 24(33): 4287-4292.
|
[7]
|
Deshmukh, H., Barker, E., Anbarasan, T., et al. (2018) Calcium Channel Blockers Are Associated with Improved Survival and Lower Cardiovascular Mortality in Patients with Renovascular Disease. Cardiovascular Therapeutics, 36, e12474. https://doi.org/10.1111/1755-5922.12474
|
[8]
|
Touyz, R.M., Alves-Lopes, R., Rios, F.J., et al. (2018) Vascular Smooth Muscle Contraction in Hypertension. Cardiovascular Research, 114, 529-539. https://doi.org/10.1093/cvr/cvy023
|
[9]
|
梁美云, 冯正平. 钙与心脑血管疾病的关系及其作用机制[J]. 中华骨质疏松和骨矿盐疾病杂志, 2020, 13(2): 177-183.
|
[10]
|
于凤至, 孙朋, 刘淑卉. G蛋白偶联受体在运动调控动脉舒张过程中的机制[J]. 中国体育科技, 2021, 57(10): 79-88.
|
[11]
|
Kurabayashi, M, (2019) Molecular Mechanism of Vascular Calcification. Clinical Calcium, 29, 157-163.
|
[12]
|
魏伟荣, 华山, 吴克勤, 等. 血清甲状旁腺激素对老年高血压患者心脏舒张功能的影响[J]. 中国临床保健杂志, 2020, 23(2): 191-194.
|
[13]
|
Fisher, S.B, and Perrier, N.D, (2020) Primary Hyperparathyroidism and Hypertension. Gland Surgery, 9, 142-149. https://doi.org/10.21037/gs.2019.10.21
|
[14]
|
Osto, E., Fallo, F., Pelizzo, M.R., et al. (2012) Coronary Microvascular Dysfunction Induced by Primary Hyperparathyroidism Is Restored after Parathyroidectomy. Circulation, 126, 1031-1039. https://doi.org/10.1161/CIRCULATIONAHA.111.081307
|
[15]
|
李晨, 李蓉, 李立. 动脉粥样硬化研究: 缘起、观点及发展趋势[J]. 临床医学进展, 2022, 12(5): 4934-4950.
|
[16]
|
Frey, S., Mirallié, É., Cariou, B. and Blanchard, C. (2021) Impact of Parathyroidectomy on Cardiovascular Risk in Primary Hyperparathyroidism: A Narrative Review. Nutrition, Metabolism, and Cardiovascular Diseases, 31, 981-996. https://doi.org/10.1016/j.numecd.2020.12.029
|
[17]
|
Koubaity, O., Mandry, D., Nguyen-Thi, P.L., et al. (2020) Coronary Artery Disease Is More Severe in Patients with Primary Hyperparathyroidism. Surgery, 167, 149-154. https://doi.org/10.1016/j.surg.2019.05.094
|
[18]
|
Beysel, S., Caliskan, M., Kizilgul, M., et al. (2019) Parathyroidectomy Improves Cardiovascular Risk Factors in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism. BMC Cardiovascular Disorders, 19, Article No. 106. https://doi.org/10.1186/s12872-019-1093-4
|
[19]
|
Kim, H.L., Chung, J., Kim, K.J., et al. (2022) Lifestyle Modification in the Management of Metabolic Syndrome: Statement from Korean Society of CardioMetabolic Syndrome (KSCMS). Korean Circulation Journal, 52, 93-109. https://doi.org/10.4070/kcj.2021.0328
|
[20]
|
Procopio, M., Barale, M., Bertaina, S., et al. (2014) Cardiovascular Risk and Metabolic Syndrome in Primary Hyperparathyroidism and Their Correlation to Different Clinical Forms. Endocrine, 47, 581-589. https://doi.org/10.1007/s12020-013-0091-z
|
[21]
|
YenerOzturk, F., Erol, S., Canat, M.M., et al. (2016) Patients with Normocalcemic Primary Hyperparathyroidism May Have Similar Metabolic Profile as Hypercalcemic Patients. Endocrine Journal, 63, 111-118. https://doi.org/10.1507/endocrj.EJ15-0392
|
[22]
|
Reid, I.R., Gamble, G.D. and Bolland, M.J. (2016) Circulating Calcium Concentrations, Vascular Disease and Mortality: A Systematic Review. Journal of Internal Medicine, 279, 524-540. https://doi.org/10.1111/joim.12464
|
[23]
|
Kobylecki, C.J., Nordestgaard, B.G. and Afzal, S. (2021) Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study. Clinical Chemistry, 67, 265-275. https://doi.org/10.1093/clinchem/hvaa245
|
[24]
|
Bandeira, F., De Moura Nóbrega, J., De Oliveira, L.B., et al. (2022) Medical Management of Primary Hyperparathyroidism. Archives of Endocrinology and Metabolism, 66, 689-693. https://doi.org/10.20945/2359-3997000000558
|
[25]
|
Orr-Walker, B.J., Evans, M.C., Clearwater, J.M., et al. (2000) Effects of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism: Four-Year Follow-Up and Comparison with Healthy Postmenopausal Women. Archives of Internal Medicine, 160, 2161-2166. https://doi.org/10.1001/archinte.160.14.2161
|
[26]
|
Rubin, M.R., Lee, K.H., McMahon, D.J. and Silverberg, S.J. (2003) Raloxifene Lowers Serum Calcium and Markers of Bone Turnover in Postmenopausal Women with Primary Hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism, 88, 1174-1178. https://doi.org/10.1210/jc.2002-020667
|
[27]
|
ACTIVE研究工作组. 西那卡塞治疗中国维持性血液透析继发性甲状旁腺功能亢进的多中心临床研究(ACTIVE)方案[J]. 肾脏病与透析肾移植杂志, 2020, 29(5): 478-483.
|
[28]
|
Rydberg, E., Birgander, M., Bondeson, A.G., et al. (2010) Effect of Successful Parathyroidectomy on 24-Hour Ambulatory Blood Pressure in Patients with Primary Hyperparathyroidism. International Journal of Cardiology, 142, 15-21. https://doi.org/10.1016/j.ijcard.2008.12.027
|
[29]
|
Graff-Baker, A.N., Bridges, L.T., Chen, Q., et al. (2020) Parathyroidectomy for Patients with Primary Hyperparathyroidism and Associations with Hypertension. JAMA Surgery, 155, 32-39. https://doi.org/10.1001/jamasurg.2019.3950
|
[30]
|
Ejlsmark-Svensson, H., Rolighed, L. and Rejnmark, L. (2019) Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial. The Journal of Clinical Endocrinology and Metabolism, 104, 3223-3232. https://doi.org/10.1210/jc.2018-02456
|
[31]
|
Karakose, M., Caliskan, M., Arslan, M.S., et al. (2017) The Impact of Parathyroidectomy on Serum ADAMTS1, ADAMTS4 Levels, Insulin Resistance, and Subclinical Cardiovascular Disease in Primary Hyperparathyroidism. Endocrine, 55, 283-288. https://doi.org/10.1007/s12020-016-1175-3
|
[32]
|
Norenstedt, S., Pernow, Y., Brismar, K., et al. (2013) Primary Hyperparathyroidism and Metabolic Risk Factors, Impact of Parathyroidectomy and Vitamin D Supplementation, and Results of A Randomized Double-Blind Study. European Journal of Endocrinology, 169, 795-804. https://doi.org/10.1530/EJE-13-0547
|
[33]
|
Luigi, P., Chiara, F.M., Laura, Z., et al. (2012) Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results. International Journal of Endocrinology, 2012, Article ID: 408295. https://doi.org/10.1155/2012/408295
|
[34]
|
Farahnak, P., Lärfars, G., Sten-Linder, M. and Nilsson, I.L. (2011) Mild Primary Hyperparathyroidism: Vitamin D Deficiency and Cardiovascular Risk Markers. The Journal of Clinical Endocrinology and Metabolism, 96, 2112-2118. https://doi.org/10.1210/jc.2011-0238
|
[35]
|
Hagström, E., Lundgren, E., Lithell, H., et al. (2002) Normalized Dyslipidaemia after Parathyroidectomy in Mild Primary Hyperparathyroidism: Population-Based Study over Five Years. Clinical Endocrinology, 56, 253-260. https://doi.org/10.1046/j.0300-0664.2001.01468.x
|
[36]
|
Godang, K., Lundstam, K., Mollerup, C., et al. (2018) The Effect of Surgery on Fat Mass, Lipid and Glucose Metabolism in Mild Primary Hyperparathyroidism. Endocrine Connections, 7, 941-948. https://doi.org/10.1530/EC-18-0259
|
[37]
|
Schillaci, G., Pucci, G., Pirro, M., et al. (2011) Large-Artery Stiffness: A Reversible Marker of Cardiovascular Risk in Primary Hyperparathyroidism. Atherosclerosis, 218, 96-101. https://doi.org/10.1016/j.atherosclerosis.2011.05.010
|
[38]
|
Tuna, M.M., Doğan, B.A., Arduç, A., et al. (2015) Impaired Endothelial Function in Patients with Mild Primary Hyperparathyroidism Improves after Parathyroidectomy. Clinical Endocrinology, 83, 951-956. https://doi.org/10.1111/cen.12666
|
[39]
|
Ekmekci, A., Abaci, N., Colak Ozbey, N., et al. (2009) Endothelial Function and Endothelial Nitric Oxide Synthase Intron 4a/B Polymorphism in Primary Hyperparathyroidism. Journal of Endocrinological Investigation, 32, 611-616. https://doi.org/10.1007/BF03346518
|